Browsing Tag

pharmacodynamics

Phathom Pharmaceuticals Presents New Data Evaluating First-in-Class…

Eli Pacheco Oct 23, 2022 0

FLORHAM PARK, N.J., Oct. 23, 2022 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments…

Health

LAVA Therapeutics to Present On-Mechanism Pharmacodynamics Data from the Phase 1/2a…

Eli Pacheco Oct 7, 2022 0

UTRECHT, The Netherlands and PHILADELPHIA, Oct. 07, 2022 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage immuno-oncology company focused on developing its…

Health

Phathom Pharmaceuticals Announces New Data at ACG 2021 Annual Scientific Meeting

Eli Pacheco Oct 25, 2021 0

Data from Phase 3 PHALCON-HP trial highlighted in oral presentation and recognized with the ACG Governors Award for Excellence in Clinical ResearchPhase 1 population PK data abstract…

Health

Phathom Pharmaceuticals Announces Results from VONO-103, a Phase 1 Study Evaluating…

Eli Pacheco Sep 27, 2021 0

Vonoprazan 20 mg demonstrated significantly greater acid suppressive effects over the 7-day study period compared to lansoprazole (PREVACID®) 30 mg, a proton pump inhibitor (PPI) FLORHAM…